Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 25INDUSTRY 5OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Head and Neck Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1Colorectal Neoplasms 1

Interventions

Irinotecan 6S 1 (combination) 4Oxaliplatin 3palbociclib 2durvalumab 2Tamoxifen 2Radiation 2Erlotinib Hydrochloride 2Cetuximab 2Capecitabine 2tremelimumab 1trametinib 1titanium silicide 1sintilimab 1olaparib 1nilotinib 1glasdegib 1genexol-PM 1futibatinib 1dabrafenib 1ceritinib 1capmatinib 1anlotinib 1Temozolomide 1Talc 1Surgical Procedures, Operative 1Radiosurgery 1Pancreatectomy 1Paclitaxel 1Methylene Blue 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasm Metastasis × Erlotinib Hydrochloride × Clear all
NCT00784667 2010-11-30

Dux

Austin Health

Phase 2 Unknown
50 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00268684 2006-02-28

Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
381 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡